Insulin resistance correlates with the arterial stiffness before glucose intolerance

Internal Medicine

Volumn 53, Issue 3, 2014, Pages 189-194

  Fang, Fu Sheng ^a   Liu, Min Yan ^a   Cheng, Xiao Ling ^a   Zhong, Wen Wen ^a   Miao, Xin Yu ^a   Li, Jian ^a   Li, Chun Lin ^a   Tian, Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Arterial stiffness; Glucose intolerance; Insulin resistance

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEART RATE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PULSE WAVE; QUESTIONNAIRE; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84893442594     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.0690     Document Type: Article

References (31)

1. Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gon-zaga Diabetes Study. Diabetes Care 34: 2237-2243, 2011.
2. Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116: 151-157, 2007.
3. Riddle MC, Ambrosius WT, Brillon DJ, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 33: 983-990, 2010.
4. de Rooij SR, Dekker JM, Kozakova M, et al. Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. Eur J Endocrinol 161: 223-230, 2009.
5. Oterdoom LH, de Vries AP, Gansevoort RT, de Jong PE, Gans RO, Bakker SJ. Fasting insulin is a stronger cardiovascular risk factor in women than in men. Atherosclerosis 203: 640-646, 2009.
6. de Boer IH, Katz R, Chonchol MB, et al. Insulin resistance, cysta-tin C, and mortality among older adults. Diabetes Care 35: 1355-1360, 2012.
7. Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 26: 615-622, 2003.
8. Hung CS, Lin JW, Hsu CN, et al. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis 19: 241-246, 2009.
9. Webb DR, Khunti K, Silverman R, et al. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetolo-gia 53: 1190-1198, 2010.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
11. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 33: e93, 2010.
12. Tomiyama H, Koji Y, Yambe M, et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 45: 997-1003, 2005.
13. Mikhail N, Tuck ML. Insulin and the vasculature. Curr Hypertens Rep 2: 148-153, 2000.
14. Zeng G, Nystrom FH, Ravichandran LV, et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101: 1539-1545, 2000.
15. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006.
16. Hamburg NM, Larson MG, Vita JA, et al. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 101: 82-88, 2008.
17. Cubbon RM, Kahn MB, Wheatcroft SB. Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci (Lond) 117: 173-190, 2009.
18. Arcaro G, Cretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 105: 576-582, 2002.
19. Libman IM, Barinas-Mitchell E, Bartucci A, Chaves-Gnecco D, Robertson R, Arslanian S. Fasting and 2-hour plasma glucose and insulin: relationship with risk factors for cardiovascular disease in overweight nondiabetic children. Diabetes Care 33: 2674-2676, 2010.
20. Lautt WW. Postprandial insulin resistance as an early predictor of cardiovascular risk. Ther Clin Risk Manag 3: 761-770, 2007.
21. Li CH, Wu JS, Yang YC, Shih CC, Lu FH, Chang CJ. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose. J Clin Endocrinol Metab 97: E658-E662, 2012.
22. Shin JY, Lee HR, Lee DC. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 10: 30, 2011.
23. Xu L, Jiang CQ, Lam TH, et al. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD. Metabolism 59: 367-372, 2010.
24. Niijima K, Muranaka Y, Ando T, et al. Elevated 1-h plasma glucose following 75-g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose tolerance. Diabet Med 29: e457-e460, 2012.
25. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
26. Yanase M, Takatsu F, Tagawa T, et al. Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance. Circ J 68: 47-52, 2004.
27. Ausk KJ, Boyko EJ, Ioannou GN. Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care 33: 1179-1185, 2010.
28. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121: 505-511, 2010.
29. Park JS, Nam JS, Cho MH, et al. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive post-menopausal women. Menopause 17: 779-784, 2010.
30. Patarrao RS, Lautt WW, Afonso RA, et al. Postprandial but not fasting insulin resistance is an early identifier of dysmetabolism in overweight subjects. Can J Physiol Pharmacol 90: 923-931, 2012.
31. Urbina EM, Gao Z, Khoury PR, Martin LJ, Dolan LM. Insulin resistance and arterial stiffness in healthy adolescents and young adults. Diabetologia 55: 625-631, 2012.